Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-23-202969
Filing Date
2023-08-03
Accepted
2023-08-03 16:59:56
Documents
2
Group Members
ABUDE UMARIPILLAR INVEST CORPPILLAR PARTNERS FOUNDATION, L.P.YOUSSEF EL ZEIN

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d505085dsc13da.htm SC 13D/A 124219
2 EX-99.1 d505085dex991.htm EX-99.1 6049
  Complete submission text file 0001193125-23-202969.txt   132182
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
Aceragen, Inc. (Subject) CIK: 0000861838 (see all company filings)

EIN.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-50211 | Film No.: 231141018
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address STARCO CTR, BLOC B, 3RD FLOOR OMAR DAUOK STREET BEIRUT M8 2020-3313
Business Address STARCO CTR, BLOC B, 3RD FLOOR OMAR DAUOK STREET BEIRUT M8 2020-3313 961 1 363 362
Pillar Pharmaceuticals 6, L.P. (Filed by) CIK: 0001783584 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A